Data Insights
By Company Name
No filters selected
By Disease Name
No filters selected
By Drug Name
No filters selected
By Themes
No filters selected
Showing 2 results out of 2
Data Insights
DD-01 by D&D Pharmatech for Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD): Likelihood of Approval
DD-01 is under clinical development by D&D Pharmatech and currently in Phase II for Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD)....
Data Insights
DD-01 by D&D Pharmatech for Metabolic Dysfunction-Associated Steatohepatitis (MASH): Likelihood of Approval
DD-01 is under clinical development by D&D Pharmatech and currently in Phase II for Metabolic Dysfunction-Associated Steatohepatitis (MASH). According to...